文献速递胰腺与胆道疾病

基于算法的慢性胰腺炎管理:全国性阶梯楔形整群随机对照试验

Algorithm-Based Care for Treating Chronic Pancreatitis: A Nationwide Stepped-Wedge Cluster Randomized Controlled Trial.
PubMed 文献 · Am J Gastroenterol · 2026-03-17

该研究在荷兰26个中心开展阶梯楔形整群随机对照试验,纳入418例慢性胰腺炎患者,比较循证管理算法与常规实践。结果显示算法管理虽改善疼痛评分但未达预设临床阈值,生活质量无显著变化;方案依从性提高与更好结局相关,尤其在基线严重疼痛或低生活质量者中。

要点

  • 循证管理算法未在所有慢性胰腺炎患者中优于常规实践。
  • 疼痛评分改善未达预设的临床相关阈值,生活质量无显著变化。
  • 提高方案依从性可显著改善结局,尤其对基线严重疼痛或低生活质量者。

核心结论

  • 循证管理算法在改善所有慢性胰腺炎患者生活质量和疼痛严重程度方面未优于标准实践。
  • 亚组分析显示,提高方案依从性可带来显著更好的结局,尤其在基线严重疼痛或低生活质量患者中。

研究设计与样本

  • 全国性阶梯楔形整群随机对照试验,在荷兰26个中心(代表6个医疗区域)开展。
  • 纳入418例明确诊断的慢性胰腺炎患者,在算法实施时正接受消化科或外科医生积极治疗。
  • 比较当前实践与循证管理算法引导的照护,采用意向性分析,总研究时长35个月。

主要发现

  • 算法引导照护改善了Izbicki疼痛评分(估计值:-1.72,97.5% CI:-3.02至-0.41,P < 0.001),但未达到预设阈值。
  • 胰腺炎生活质量量表评分无显著变化(估计值:0.42,97.5% CI:-0.44至1.27,P = 0.27)。
  • 完成随访患者的方案依从性中位数为68.8%(IQR,56.1-83.9)。
  • 按基线评分和依从性分层分析未显示临床相关改善。

关键数值与推荐

  • 共同主要终点为疼痛严重程度(Izbicki疼痛评分)和生活质量(胰腺炎生活质量量表评分)。
  • 临床相关效应阈值定义为最大评分的10%,基于专家共识德尔菲会议确定。

临床怎么用

  • 在慢性胰腺炎管理中应重视方案依从性,尤其对基线严重疼痛或低生活质量患者。
  • 循证管理算法可作为改善照护的工具,但需确保高依从性以实现临床获益。

局限性

  • 方案依从性中位数仅为68.8%,可能影响干预效果的充分体现。
  • 分层分析未显示临床相关改善,整体研究未达到主要终点阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Chronic pancreatitis strongly impairs patients' quality of life through pain and functional insufficiencies, which may be improved by implementing an evidence-based management algorithm. This study aimed to improve quality of life and reduce pain by increasing guideline adherence, using an evidence-based management algorithm, addressing exocrine and endocrine pancreatic insufficiency, nutritional status, bone health, pain management, and lifestyle. METHODS: A nationwide stepped-wedge cluster-randomized controlled trial was performed across 26 Dutch centers collaborating in the Dutch Pancreatitis Study Group, representing 6 healthcare regions. Current practice was compared with evidence-based management algorithm-guided care. Patients with a definite diagnosis of chronic pancreatitis, who were actively receiving care from a gastroenterologist or surgeon at the time of algorithm implementation, were included during the current practice phase and followed longitudinally. Coprimary endpoints were pain severity (Izbicki Pain Score) and quality of life (Pancreatitis Quality-of-Life Instrument score), with a clinically relevant effect threshold defined as 10% of the maximum score, based on an expert consensus Delphi meeting. Analyses were performed according to intention-to-treat. Secondary outcomes included protocol adherence and several clinical outcomes. Total study duration was 35 months. RESULTS: Overall, 418 patients with chronic pancreatitis were included. Evidence-based management algorithm-guided care improved Izbicki Pain Scores (estimate: -1.72, 97.5% CI: -3.02 to -0.41, P < 0.001), without reaching the predefined threshold. No significant change in Pancreatitis Quality-of-Life Instrument score was observed (estimate: 0.42, 97.5% CI: -0.44 to 1.27, P = 0.27). Median protocol adherence in patients who completed the follow-up period was 68.8% (IQR, 56.1-83.9). Stratified analyses by baseline scores and adherence did not yield clinically relevant improvements. DISCUSSION: We found no superiority of an evidence-based management algorithm over standard practice in improving quality of life or pain severity in all patients with chronic pancreatitis. However, by subgroup analyses, increased protocol adherence led to significantly better outcomes, especially in those with severe pain or low quality of life at baseline. These findings highlight both the complexity of, and the need for, dedicated protocol adherence in chronic pancreatitis management.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. de Rijk FEM, Thierens NDE, van Veldhuisen CL, et al. Algorithm-Based Care for Treating Chronic Pancreatitis: A Nationwide Stepped-Wedge Cluster Randomized Controlled Trial. Am J Gastroenterol. 2026. PMID: 41841610. doi:10.14309/ajg.0000000000003995

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。